Insider · CIK 0001618670

Girao Tiago

Reports to the SEC for 3 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001618670

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-23	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−6,798 sh	$38.69	−$263K	240,798
2026-06-26	IMVTImmunovant, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	283,505
2026-06-26	IMVTImmunovant, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$15.90	+$159K	257,596
2026-06-26	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$38.46	−$385K	247,596
2026-04-23	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−25.8K sh	$29.62	−$763K	247,596
2026-04-07	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+94K sh	—	—	94,002
2026-04-07	IMVTImmunovant, Inc.A Award	Chief Financial Officer	AAward	+65K sh	—	—	273,356
2025-05-01	IMVTImmunovant, Inc.A Award	Chief Financial Officer	AAward	+208K sh	—	—	208,388
2025-05-01	IMVTImmunovant, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+294K sh	—	—	293,505
2024-05-23	Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,800 sh	—	—	0
2024-05-23	Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,800 sh	—	—	0
2024-05-23	Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,800 sh	—	—	0
2023-05-23	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-06-07	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-05-16	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2021-04-08	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+36K sh	—	—	36,000
2018-07-25	CNSYCERENOME, INC. · Warrants (Right to Buy)X Exercise of In-Money	VP & Chief Financial Officer	XExercise of In-Money	+1,050 sh	—	—	1,050
2018-07-25	CNSYCERENOME, INC. · Series C Preferred StockX Exercise of In-Money	VP & Chief Financial Officer	XExercise of In-Money	+1 sh	—	—	1
2018-07-25	CNSYCERENOME, INC. · Subscription Rights (Right to Buy)X Exercise of In-Money	VP & Chief Financial Officer	XExercise of In-Money	−1 sh	—	—	0
2017-11-28	CNSYCERENOME, INC. · Warrants (Right to Buy)X Exercise of In-Money	VP & Chief Financial Officer	XExercise of In-Money	+1,800 sh	—	—	1,800
2017-11-28	CNSYCERENOME, INC. · Series B Preferred StockX Exercise of In-Money	VP & Chief Financial Officer	XExercise of In-Money	+1 sh	—	—	1
2017-11-28	CNSYCERENOME, INC. · Subscription Rights (Right to Buy)X Exercise of In-Money	VP & Chief Financial Officer	XExercise of In-Money	−1 sh	—	—	0
2017-03-08	CNSYCERENOME, INC. · Incentive Stock Option (right to buy)A Award	VP & Chief Financial Officer	AAward	+42K sh	—	—	42,000
2017-03-08	CNSYCERENOME, INC. · Incentive Stock Option (right to buy)A Award	VP & Chief Financial Officer	AAward	+31.1K sh	—	—	31,100
2016-06-15	CNSYCERENOME, INC. · Subscription Rights (Right to Buy)X Exercise of In-Money	VP & Chief Financial Officer	XExercise of In-Money	−5,667 sh	—	—	0
2016-06-15	CNSYCERENOME, INC. · Warrants (Right to Buy)X Exercise of In-Money	VP & Chief Financial Officer	XExercise of In-Money	+2,833 sh	—	—	2,833
2016-06-15	CNSYCERENOME, INC.X Exercise of In-Money	VP & Chief Financial Officer	XExercise of In-Money	+5,667 sh	—	—	14,084
2016-01-28	CNSYCERENOME, INC.A Award	VP & Chief Financial Officer	AAward	+35.3K sh	—	—	126,250
2016-01-28	CNSYCERENOME, INC.A Award	VP & Chief Financial Officer	AAward	+35.3K sh	—	—	123,250
2016-01-04	CNSYCERENOME, INC. · Employee Stock OptionA Award	VP & Chief Financial Officer	AAward	+350K sh	—	—	619,830
2015-08-18	CNSYCERENOME, INC.P Purchase	VP & Chief Financial Officer	PPurchase	+25K sh	$0.39	+$9,750	88,000
2015-01-30	CNSYCERENOME, INC. · Employee Stock OptionA Award	VP & Chief Financial Officer	AAward	+120K sh	—	—	270,000
2014-11-12	CNSYCERENOME, INC.P Purchase	VP & Chief Financial Officer	PPurchase	+44.1K sh	$0.39	+$17.2K	60,000
2014-11-11	CNSYCERENOME, INC.P Purchase	VP & Chief Financial Officer	PPurchase	+15.9K sh	$0.39	+$6,196.71	15,889
2014-09-02	CNSYCERENOME, INC. · Incentive Stock Option (Right to Buy)A Award	VP & Chief Financial Officer	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Jul 244
Girao Tiago0001618670-26-000004
SEC(opens sec.gov)
Jun 264
Girao Tiago0001764013-26-000072
SEC(opens sec.gov)
Apr 244
Girao Tiago0001764013-26-000056
SEC(opens sec.gov)
Apr 94
Girao Tiago0001764013-26-000032
SEC(opens sec.gov)
May 54
Girao Tiago0001415889-25-012047
SEC(opens sec.gov)
May 234
Girao Tiago0001415889-24-014341
SEC(opens sec.gov)
May 244
Girao Tiago0001209191-23-031945
SEC(opens sec.gov)
Jun 94
Girao Tiago0001209191-22-035284
SEC(opens sec.gov)
May 184
Girao Tiago0001209191-22-030046
SEC(opens sec.gov)
Apr 124
Girao Tiago0001209191-21-026381
SEC(opens sec.gov)
Jul 274
Girao Tiago0001209191-18-044206
SEC(opens sec.gov)
Nov 294
Girao Tiago0001209191-17-062896
SEC(opens sec.gov)

Companies

Address

C/O IMMUNOVANT, INC. 1000 PARK FORTY PLAZA, SUITE 210

DURHAM, NC, 27713